1. Introduction {#sec1-healthcare-08-00145}
===============

After the first reported case of coronavirus disease 2019 (COVID-19) in Hubei Province of China in December 2019, COVID-19 cases have been reported in most countries worldwide. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV) has been rapidly spreading, with unprecedented propagation, because of its highly infectious nature. The World Health Organization declared the COVID-19 outbreak a pandemic on 11 March 2020 \[[@B1-healthcare-08-00145],[@B2-healthcare-08-00145],[@B3-healthcare-08-00145]\]. The fatality rate of COVID-19 is 2--6% and is much higher in older populations and those with underlying diseases \[[@B1-healthcare-08-00145],[@B2-healthcare-08-00145],[@B3-healthcare-08-00145]\]. The number of suspected or symptomatic individuals with COVID-19 is continuously increasing; hence, screening clinics, separated from other existing clinics, are being set up in several hospitals in each community.

In Daegu, South Korea, a rapid surge in COVID-19 cases occurred in late February and early March 2020. Over 5000 confirmed cases of COVID-19 were reported during this period in Daegu. For efficient and safe screening, some hospitals in Daegu implemented a drive-through (DT) screening system \[[@B4-healthcare-08-00145]\]. The individuals who used this system could provide a sample for SARS-CoV-2 testing without leaving their cars. We believe that this system is helpful for conducting rapid and safe testing during the current COVID-19 outbreak in Daegu.

In the current study, we evaluated the efficiency of a DT screening system for SARS-CoV-2 by comparing it with a conventional screening system. Moreover, we reviewed the results of SARS-CoV-2 screening (for samples collected via DT and conventional systems) in a single university hospital during the COVID-19 outbreak in Daegu, South Korea.

2. Methods {#sec2-healthcare-08-00145}
==========

This study was approved by the Institutional Review Board (IRB) of Yeungnam University Hospital, and the requirement for informed consent was waived by the Ethics Committee. We reviewed and analyzed the data of a SARS-CoV-2 screening clinic at Yeungnam University Hospital, Daegu, which is one of the four university hospitals in Daegu. The data were collected using a computerized system. At the time of patient examination, the staff input the data, such as the presence of COVID-19 symptoms and a history of contact with COVID-19 patients, into the hospital's computerized system. In addition, we described the details of the DT screening system and the conventional screening system and compared the two systems. This research was approved by IRB at Yeungnam University Hospital (2020-03-101).

3. Results {#sec3-healthcare-08-00145}
==========

3.1. Operational Differences between the Conventional and Drive-Through Systems {#sec3dot1-healthcare-08-00145}
-------------------------------------------------------------------------------

### 3.1.1. Conventional System {#sec3dot1dot1-healthcare-08-00145}

The conventional specimen collection system used a negative-pressure tent. The medical staff working in the temporary buildings wore personal protective equipment, including inner and outer gloves; an N95 respirator; an eye shield, a face shield, or goggles; a hooded coverall or gown. The outer gloves and disposable plastic apron (AP) gowns were changed after contact with every patient. The tent was divided into three sections---the section through which the individual to be tested entered (Section A), the section where the medical staff completed the questionnaires (Section B), and the section where the specimen for testing was collected (Section C) ([Figure 1](#healthcare-08-00145-f001){ref-type="fig"}). When a testee entered the negative-pressure tent (Section A), the medical staff in Section B interviewed the testee. These two sections (A and B) were separated by transparent plastic. After completing the questionnaire, the testee moved to Section C, where the test specimens were collected. In Section C, three or four medical staff were waiting---one was responsible for collecting the payment for the test, one was responsible for specimen collection, and the others were responsible for sterilizing the space after the individual exited the tent. To prevent cross-contamination by testees, all sections, except Section B, were sterilized for at least 30 minutes before the next testee entered.

### 3.1.2. Drive-Through System {#sec3dot1dot2-healthcare-08-00145}

The procedure for the DT specimen collection system was as follows: entrance, registration and questionnaire completion, examination, specimen collection, and receipt of instructions and information ([Figure 2](#healthcare-08-00145-f002){ref-type="fig"}) \[[@B4-healthcare-08-00145]\]. For registration and questionnaire completion, examination, specimen collection, and receipt of instructions and the information leaflet, one temporary outside building was built for each section; therefore, four temporary buildings were built in total. One or two medical staff were present in each section and were completely isolated from the outdoor environment. The medical staff working in the temporary buildings wore personal protective equipment, including inner and outer gloves; an N95 respirator; an eye shield, a face shield, or goggles; a hooded coverall or gown. The outer gloves and disposable plastic apron (AP) gowns were changed after contact with every patient. In the registration and questionnaire section, the identification card of the testee was scanned and automatically transferred to the computerized system of the hospital to avoid direct contact with testees. In the registration and questionnaire and examination sections, microphones were installed inside and outside of the temporary buildings so that the medical staff could communicate with the testee without direct contact. In the specimen collection section, the driver opened the window of the car and collected his or her own specimen. In the instructions and information section, the medical staff provided information regarding when the results would be available through a microphone. The entire service could be provided to individuals without leaving their cars. Unlike conventional systems, the DT system did not require sterilization of spaces between testees, thus markedly reducing the preparation times. The total time spent on each testee was 5--7 min. Comparing the time taken for the COVID-19 test between the DT system (5--7 min) and conventional system (30 min), the DT system was 4--6 times more efficient than the conventional screening system.

3.2. The Difference in Specimen Collection Ability between Drive-Through and Conventional Systems {#sec3dot2-healthcare-08-00145}
-------------------------------------------------------------------------------------------------

We compared the number of specimens collected by the two different systems over a 14-day period (26 February 2020 to 10 March 2020), during which both systems were operating simultaneously. Through this, we aimed to indirectly compare the efficiency of the two systems. In the DT and conventional systems, the number of specimens collected per day were 241.7 and 41.4, respectively (3384 (DT system) vs. 580 (conventional system)). According to the total number of tests performed during the 14-day period, the efficiency of the DT system was 5.8 times higher than that of the conventional screening system. In addition, per test, the DT system was 4--6 times faster than the conventional system (5--7 min vs. 30 min). Because of the higher efficiency of the DT system, as of 11 March 2020, we stopped using the conventional system and used only the DT system to collect specimens for SARS-CoV-2 testing.

3.3. Laboratory Data {#sec3dot3-healthcare-08-00145}
--------------------

Real-time polymerase chain reaction (Allplex^™^ 2019-nCoV Assay, Seegene^®^, Seoul, Korea) was used for SARS-CoV-2 testing. From 17 January to mid-February 2020, this test was performed in less than 10 individuals per day. The first confirmed case of COVID-19 was reported on 18 February 2020, and a gradual increase in the number of tests and confirmed cases followed. After the sudden outbreak of COVID-19 in Daegu, the number of tests, newly confirmed cases, and positive rate sharply increased. In mid-March 2020, 150--450 individuals were being tested for SARS-CoV-2 daily ([Figure 3](#healthcare-08-00145-f003){ref-type="fig"} and [Table 1](#healthcare-08-00145-t001){ref-type="table"}).

In total, 6211 individuals underwent SARS-CoV-2 testing. Overall, 5151 (82.93%) and 1060 (17.07%) individuals provided specimens through DT and conventional collection systems, respectively. Further, 217 individuals tested positive for SARS-CoV-2 (positive rate: 3.50%). Of the 6211 individuals, 3368 were symptomatic or had a history of contact with COVID-19 patients, and 142 of them tested positive for SARS-CoV-2 (positive rate: 4.22%). Further, 2843 patients were asymptomatic and had no history of contact with COVID-19 patients, and 75 of them tested positive for SARS-CoV-2 (positive rate: 2.64%) ([Table 2](#healthcare-08-00145-t002){ref-type="table"}). A large number of individuals aged 20 to 59 years, \>1000 per age range, underwent SARS-CoV-2 testing, and the positive rate was 1.5--4.6% ([Table 3](#healthcare-08-00145-t003){ref-type="table"}). In contrast, a relatively small number of individuals aged 60 to 89 years underwent SARS-CoV-2 testing, but the positive rate was relatively high (6.8--14.0%). Of the 211 patients with positive test results, 89 (41.01%) were men, and 128 (58.99%) were women.

During the 14-day period (26 February 2020 to 10 March 2020), when DT and conventional systems were administered simultaneously, 3964 individuals underwent SARS-CoV-2 testing. According to the screening system, the rates of positive test results were 4.11% (DT system) and 5.69% (conventional system). Of the 3384 individuals who used the DT system, 1812 (53.55%) were symptomatic or had a history of contact with COVID-19 patients, while 1572 (46.45%) were asymptomatic and had no history of contact with COVID-19 patients. Of the 580 individuals who used the conventional system, 332 (57.24%) were symptomatic or had a history of contact with COVID-19 patients, while 248 (42.76%) were asymptomatic and had no history of contact with COVID-19 patients ([Table 4](#healthcare-08-00145-t004){ref-type="table"}).

4. Discussion {#sec4-healthcare-08-00145}
=============

For managing pandemic diseases, such as COVID-19, not only accuracy but also the efficiency of diagnoses, such as the time taken to establish a diagnosis and the number of tests performed, are of utmost importance. Since SARS-CoV-2 is highly transmissible, rapid diagnosis and sufficient testing capacity are essential for the management of COVID-19 \[[@B1-healthcare-08-00145],[@B2-healthcare-08-00145],[@B3-healthcare-08-00145]\]. In our study, two specimen collection systems---conventional and DT---were examined. The DT system was approximately 9 times more efficient at collecting specimens for testing. These results suggested that the DT system was more efficient and useful for effective COVID-19 management. We believed that the wide-scale use of DT systems could significantly contribute to the efficient diagnosis of COVID-19.

In this study, positive results were seen in around 2.64% of asymptomatic individuals. These results supported that lack of symptoms should not be an indication of exclusion for SARS-CoV-2 testing. In other words, testing might be necessary during pandemics, even when if the patient is asymptomatic or has a history of contact with infected individuals \[[@B5-healthcare-08-00145],[@B6-healthcare-08-00145]\].

In our study, we found that older individuals (aged ≥ 60 years) had a lesser tendency to undergo screening than younger individuals (aged ≤ 50 years). The positive test result rates were higher among individuals in their 60 s--80 s than among those in the lower age groups. Older individuals had a lesser tendency to undergo the COVID-19 test than younger individuals. This could be due to the fact that many older individuals are physically weak or cannot drive. To develop appropriate strategies for managing COVID-19, the government and clinicians must focus more on the older population, especially individuals aged ≥ 60 years.

During the study period, the number of tests and the cumulative number of positive patients began to increase exponentially from 20 February 2020. The main source of this rapid propagation was determined to be mass infection among a religious group (Shincheonji) in Daegu during a Sunday gathering. In this religious gathering, thousands of people were sitting close to each other in a confined space within the facility, having conversations, praying, and singing songs. The government had ordered screening tests for all the individuals in this group. Of them, 62% (\>2000 cases) tested positive for SARS-CoV-2. Moreover, throughout South Korea, mass infections occurring in churches, hospitals, nursing homes, and call centers were largely responsible for the increase in the number of COVID-19 cases. Therefore, during the COVID-19 outbreak, group meetings should be restrained, and measures should be implemented in facilities where many people are gathered to actively prevent further COVID-19 cases as SARS-CoV-2 has a high transmission rate.

As of 11 April 2020, the total positive test result rate for SARS-CoV-2 in South Korea was 2.05% (<http://ncov.mohw.go.kr/en/>). This value was lower than the positive test result rate of our study (3.49%). This might be due to the fact that our hospital is located in Daegu, which was the epicenter of the COVID-19 outbreak in South Korea; as of 11 April 2020, around 65% of COVID-19 patients in South Korea were Daegu residents.

5. Conclusions {#sec5-healthcare-08-00145}
==============

In this study, we reviewed screening clinic data for SARS-CoV-2 in a single university hospital during the COVID-19 outbreak in Daegu, South Korea. The results of the analysis showed that the DT screening system was highly efficient. The DT system was a useful option for rapid and safe testing. Furthermore, our results showed a high positive test result rate in asymptomatic patients. Therefore, expanding screening tests to asymptomatic individuals might be necessary. Larger cohort studies analyzing data from multiple hospitals are warranted for acquiring more accurate information regarding SARS-CoV-2 and COVID-19.
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![Illustration of the conventional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening process.](healthcare-08-00145-g001){#healthcare-08-00145-f001}
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![(**A**) Graph showing the cumulative number of positive and negative cases after SARS-CoV-2 testing and positive test result rate by date in the screening clinic of our university hospital. (**B**) Graph showing the daily number of positive and negative cases after SARS-CoV-2 testing.](healthcare-08-00145-g003){#healthcare-08-00145-f003}

healthcare-08-00145-t001_Table 1

###### 

A cumulative number of positive and negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases and the number of positive and negative cases by date in the screening clinic of our university hospital.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Date\        Number of Tested Cases   Cumulative Number of Negative Cases   Cumulative Number of Positive Cases   Positive Rate   Number of Negative Cases Per Day   Number of Positive Cases Per Day
  (YYYYMMDD)                                                                                                                                                           
  ------------ ------------------------ ------------------------------------- ------------------------------------- --------------- ---------------------------------- ----------------------------------
  20200127     0                        0                                     0                                     \-              0                                  0

  20200128     0                        0                                     0                                     \-              0                                  0

  20200129     1                        1                                     0                                     0               1                                  0

  20200130     1                        2                                     0                                     0               1                                  0

  20200131     0                        2                                     0                                     \-              0                                  0

  20200201     1                        3                                     0                                     0               1                                  0

  20200202     0                        3                                     0                                     \-              0                                  0

  20200203     0                        3                                     0                                     \-              0                                  0

  20200204     0                        3                                     0                                     \-              0                                  0

  20200205     0                        3                                     0                                     \-              0                                  0

  20200206     0                        3                                     0                                     \-              0                                  0

  20200207     0                        3                                     0                                     \-              0                                  0

  20200208     1                        4                                     0                                     0               1                                  0

  20200209     0                        4                                     0                                     \-              0                                  0

  20200210     3                        7                                     0                                     0               3                                  0

  20200211     2                        9                                     0                                     0               2                                  0

  20200212     1                        10                                    0                                     0               1                                  0

  20200213     0                        10                                    0                                     \-              0                                  0

  20200214     1                        11                                    0                                     0               1                                  0

  20200215     0                        11                                    0                                     \-              0                                  0

  20200216     0                        11                                    0                                     \-              0                                  0

  20200217     1                        12                                    0                                     0               1                                  0

  20200218     4                        15                                    1                                     25.00           3                                  1

  20200219     11                       26                                    1                                     0               11                                 0

  20200220     17                       37                                    7                                     35.29           11                                 6

  20200221     23                       57                                    10                                    13.04           20                                 3

  20200222     39                       90                                    16                                    15.38           33                                 6

  20200223     50                       135                                   21                                    10.00           45                                 5

  20200224     48                       177                                   27                                    12.50           42                                 6

  20200225     56                       228                                   32                                    8.93            51                                 5

  20200226     129                      347                                   42                                    7.75            119                                10

  20200227     277                      605                                   61                                    6.86            258                                19

  20200228     362                      945                                   83                                    6.08            340                                22

  20200229     332                      1256                                  104                                   6.33            311                                21

  20200301     359                      1603                                  116                                   3.34            347                                12

  20200302     444                      2019                                  144                                   6.31            416                                28

  20200303     385                      2390                                  158                                   3.64            371                                14

  20200304     355                      2728                                  175                                   4.79            338                                17

  20200305     355                      3075                                  183                                   2.25            347                                8

  20200306     238                      3307                                  189                                   2.52            232                                6

  20200307     176                      3482                                  190                                   0.57            175                                1

  20200308     120                      3599                                  193                                   2.50            117                                3

  20200309     255                      3848                                  199                                   2.35            249                                6

  20200310     177                      4020                                  204                                   2.82            172                                5

  20200311     198                      4216                                  206                                   1.01            196                                2

  20200312     174                      4387                                  209                                   1.72            171                                3

  20200313     149                      4536                                  209                                   0               149                                0

  20200314     55                       4590                                  210                                   1.82            54                                 1

  20200315     50                       4639                                  211                                   2.00            49                                 1

  20200316     111                      4747                                  214                                   2.70            108                                3

  20200317     85                       4832                                  214                                   0               85                                 0

  20200318     98                       4929                                  215                                   1.02            97                                 1

  20200319     113                      5042                                  215                                   0               113                                0

  20200320     52                       5093                                  216                                   1.92            51                                 1

  20200321     33                       5126                                  216                                   0               33                                 0

  20200322     93                       5219                                  216                                   0               93                                 0

  20200323     100                      5319                                  216                                   0               100                                0

  20200324     93                       5412                                  216                                   0               93                                 0

  20200325     73                       5484                                  217                                   1.37            72                                 1

  20200326     84                       5568                                  217                                   0               84                                 0

  20200327     155                      5723                                  217                                   0               155                                0

  20200328     51                       5774                                  217                                   0               51                                 0

  20200329     29                       5803                                  217                                   0               29                                 0

  20200330     87                       5890                                  217                                   0               87                                 0

  20200331     104                      5994                                  217                                   0               104                                0
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

healthcare-08-00145-t002_Table 2

###### 

The number of positive SARS-CoV-2 cases and positive rate according to the presence of symptoms and history of contact with coronavirus disease 2019 (COVID-19) patients.

  Classification of COVID-19 Patients According to Symptom or History of Contact   Number of Tested Individuals (*n*)   Number of Positive Cases (*n*)   Positive Rate (%)
  -------------------------------------------------------------------------------- ------------------------------------ -------------------------------- -------------------
  Symptomatic or having a history of contact with COVID-19 patients                3368                                 142                              4.22
  Asymptomatic and having no history of contact with COVID-19 patients             2843                                 75                               2.64

healthcare-08-00145-t003_Table 3

###### 

The number of tested individuals, number of SARS-CoV-2-negative and -positive cases, and positive rates according to age ranges.

  Age (Years)   Number of Tested Individuals (*n*)   Number of Negative Cases (*n*)   Number of Positive Cases (*n*)   Positive Rate (%)
  ------------- ------------------------------------ -------------------------------- -------------------------------- -------------------
  \<10          103                                  101                              2                                1.94
  10s           142                                  139                              3                                2.11
  20s           1217                                 1185                             32                               2.63
  30s           1333                                 1313                             20                               1.50
  40s           1299                                 1271                             28                               2.16
  50s           1219                                 1164                             55                               4.51
  60s           628                                  585                              43                               6.85
  70s           193                                  166                              27                               13.99
  80s           68                                   61                               7                                10.29
  90s           9                                    9                                0                                0

healthcare-08-00145-t004_Table 4

###### 

The number of SARS-CoV-2-positive cases and positive rates based on the presence of symptoms and history of contact with COVID-19 patients according to the screening system.

  Classification of COVID-19 Patients According to Symptom or History of Contact   Drive-Through System   Conventional System   Total
  -------------------------------------------------------------------------------- ---------------------- --------------------- ---------------
  Symptomatic or having a history of contact with COVID-19 patients                1812 (53.55%)          332 (57.24%)          2144 (54.09%)
  Asymptomatic and having no history of contact with COVID-19 patients             1572 (46.45%)          248 (42.76%)          1820 (45.91%)
  Positive for COVID-19                                                            139 (4.11%)            33 (5.69%)            172 (4.34%)
